2179Jiangsu Recbio Technology2179 info
$1.14info0.00%24h
Global rank13512
Market cap$361.02M
Change 7d0.00%
YTD Performance-18.05%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Jiangsu Recbio Technology (2179) Stock Overview

    Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People's Republic of China. The company is developing vaccines for the treatment of cervical cancer, and anal and genital warts, including REC603, a recombinant human papillomavirus (HPV) 9-valent vaccine that is in phase III clinical trial; REC601 and REC602 recombinant HPV bivalent vaccines, which are in phase I clinical trials; REC604a, a recombinant HPV quadrivalent vaccine that is in pre-clinical stage; and REC604b, a recombinant HPV 9-valent vaccine that is in pre-clinical stage. It also develops ReCOV, a recombinant COVID-19 vaccine candidate that is in Phase II/III trial; R520A, a messenger ribonucleic acid COVID-19 vaccine candidate that is in pre-clinical stage; REC610, a recombinant shingles vaccine that is in Phase l clinical trial; REC607, a virus vectored adult tuberculosis vaccine that is in pre-clinical stage; REC606, a recombinant adult tuberculosis vaccine that is in pre-clinical stage; REC617, a recombinant influenza quadrivalent vaccine that is in pre-clinical stage; and REC605, a recombinant hand-foot-mouth disease quadrivalent vaccine that is in pre-clinical stage. Jiangsu Recbio Technology Co., Ltd. was founded in 2011 and is headquartered in Taizhou, the People's Republic of China.

    2179 Stock Information

    Symbol
    2179
    Address
    No. 888 Yaocheng AvenueTaizhou, China
    Founded
    -
    Trading hours
    -
    Website
    https://www.recbio.cn
    Country
    🇨🇳 China
    Phone Number

    Jiangsu Recbio Technology (2179) Price Chart

    -
    Value:-

    Jiangsu Recbio Technology Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.14
    N/A
    Market Cap
    $361.02M
    N/A
    Shares Outstanding
    316.14M
    N/A
    Employees
    434.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org